JP2008509222A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509222A5
JP2008509222A5 JP2007525700A JP2007525700A JP2008509222A5 JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5 JP 2007525700 A JP2007525700 A JP 2007525700A JP 2007525700 A JP2007525700 A JP 2007525700A JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5
Authority
JP
Japan
Prior art keywords
methyloxy
naphthyridin
dihydro
oxo
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028107 external-priority patent/WO2006020561A2/en
Publication of JP2008509222A publication Critical patent/JP2008509222A/ja
Publication of JP2008509222A5 publication Critical patent/JP2008509222A5/ja
Pending legal-status Critical Current

Links

JP2007525700A 2004-08-09 2005-08-09 抗菌剤 Pending JP2008509222A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59993104P 2004-08-09 2004-08-09
PCT/US2005/028107 WO2006020561A2 (en) 2004-08-09 2005-08-09 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008509222A JP2008509222A (ja) 2008-03-27
JP2008509222A5 true JP2008509222A5 (https=) 2008-09-25

Family

ID=35908073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525700A Pending JP2008509222A (ja) 2004-08-09 2005-08-09 抗菌剤

Country Status (4)

Country Link
US (1) US20070161627A1 (https=)
EP (1) EP1784410A4 (https=)
JP (1) JP2008509222A (https=)
WO (1) WO2006020561A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017468A2 (en) * 2004-08-02 2006-02-16 Glaxo Group Limited Antibacterial agents
EP1845995A4 (en) * 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
JP2008528586A (ja) * 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP2001887B1 (en) 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
WO2007118130A2 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Antibacterial agents
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
WO2020169593A1 (en) 2019-02-19 2020-08-27 Univerza V Ljubljani Antibacterials based on monocyclic fragments coupled to aminopiperidine naphthyridine scaffold

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602864B1 (en) * 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
IL130152A0 (en) * 1996-12-13 2000-06-01 Rhone Poulenc Rorer Pharma Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclyamide compounds
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
GB9824612D0 (en) * 1998-11-10 1999-01-06 Glynwed Metal Processing Limit A blind fastening device
EP1305308B1 (en) * 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
EP1551829B1 (de) * 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP2008509222A5 (https=)
JP7297053B2 (ja) 神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解
JP2008506695A5 (https=)
JP2008507543A5 (https=)
JP2009532504A5 (https=)
JP2008505920A5 (https=)
JP4654035B2 (ja) 抗菌剤
JP2005525324A5 (https=)
JP2008502689A5 (https=)
JP2013525438A5 (https=)
WO2016197114A1 (en) Tank-binding kinase-1 protacs and associated methods of use
JP2008505926A5 (https=)
JP4704755B2 (ja) 抗菌剤
JP2005504080A5 (https=)
ES2190570T3 (es) Compuestos heterociclicos de piperazinilo para el tratamiento de la demencia.
SE0402735D0 (sv) Novel compounds
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
JP2007516194A5 (https=)
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
RU2000105266A (ru) Производные 1-(n-фениламиноалкил)-пиперазина, замещенные в положении 2 фенильного кольца
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
AR040126A1 (es) Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
DE60208178D1 (de) Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten